GF29370315
Bismuth
foil, not light tested, 50x50mm, thickness 0.005mm, permanent polyester support, 99.97%
Synonym(s):
Bismuth, BI000070
Sign Into View Organizational & Contract Pricing
All Photos(2)
About This Item
vapor pressure
<0.1 mmHg ( 20 °C)
Assay
99.97%
form
foil
manufacturer/tradename
Goodfellow 293-703-15
resistivity
129 μΩ-cm, 20°C
size × thickness
50x50 mm × 0.005 mm
bp
1560 °C (lit.)
mp
271 °C (lit.)
density
9.8 g/mL at 25 °C (lit.)
SMILES string
[Bi]
InChI
1S/Bi
InChI key
JCXGWMGPZLAOME-UHFFFAOYSA-N
Looking for similar products? Visit Product Comparison Guide
General description
For updated SDS information please visit www.goodfellow.com.
Legal Information
Product of Goodfellow
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Future medicinal chemistry, 4(11), 1495-1523 (2012-08-04)
In recent years, the chemical potential of bismuth and bismuth compounds has been actively exploited. Bismuth salts are known for their low toxicity, making them potential valuable reagents for large-scale synthesis, which becomes more obvious when dealing with products such
Bismuth in medicine.
Metal ions in biological systems, 41, 333-378 (2004-06-23)
Metallomics : integrated biometal science, 4(3), 239-243 (2012-02-24)
Helicobacter pylori causes various gastric diseases, such as gastritis, peptic ulcerations and gastric cancer. Bismuth-based triple or quadruple therapies have been commonly recommended for the treatment of H. pylori infections. Up to now, the molecular mechanisms by which bismuth inhibits
Syntheses of biodegradable and biocompatible polymers by means of bismuth catalysts.
Chemical reviews, 109(11), 5579-5594 (2009-09-26)
European journal of gastroenterology & hepatology, 25(10), 1134-1140 (2013-06-20)
Antimicrobial resistance has continued to undermine many popular anti-Helicobacter pylori therapies. Antibiotic resistance to commonly used anti-H. pylori drugs in China has increased markedly, making China an ideal site to identify regimens that remain effective despite widespread antimicrobial resistance. Bismuth
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service